Dr Bharat Pant
Senior Resident
Department of Pharmacology
Qualification: MBBS, MD
SUBJECTS CURRENTLY TEACHING
| Subject | Semester / Year |
|---|---|
| Pharmacology |
ACADEMIC QUALIFICATIONS
| Degree | Specialisation | Institute | Year of passing |
|---|---|---|---|
| MD | Pharmacology | Pt BD Sharma PGIMS, Rohtak | 2023 |
| MBBS | VCSGGIMS&R, Srinagar, Uttarakhand | 2018 |
Experience
| Institution / Organisation | Designation | Role | Tenure |
|---|---|---|---|
| Novo Nordisk, Bangalore | Global Medical Advisor | Aug 2024- Feb 2025 | |
| Advanced Centre for Treatment, 365体育直播 and Education in Cancer-TMC, Navi Mumbai | Fellow in Oncotherapeutics | Aug 2023- Jul 2024 | |
| Uttarakhand Health Services, Pithoragarh | Medical Officer | Apr 2019- Jul 2020 | |
| Department of Dermatology, HNB Base Hospital, Srinagar, Uttarakhand | House Surgeon | Mar 2018- Mar 2019 |
AREAS OF INTEREST, EXPERTISE AND RESEARCH
Area of Interest
Systemic Pharmacology, 365体育直播, Biostatistics
Area of Expertise
Oncotherapeutics, Survival studies
Area of 365体育直播
Oncology
Drug development in LMICs: could the emerging Indian model usher the southeast Asian region?
Pant B, Goda J, Gota V. Drug development in LMICs: could the emerging Indian model usher the southeast Asian region? Lancet Reg Health 365体育直播east Asia. 2024;29:100464. doi: 10.1016/j.lansea.2024.100464.
Efficacy and safety of different itraconazole regimens in the patients of recurrent dermatophytosis: An open-label randomized clinical trial.
Pant, Bharat1; Verma, Savita1; Dayal, Surabhi2. Efficacy and safety of different itraconazole regimens in the patients of recurrent dermatophytosis: An open-label randomized clinical trial. National Journal of Pharmacology and Therapeutics 1(1):26-31, 2023. doi: 10.4103/NJPT.NJPT_14_23